1. Chouraqui P, Maddahi J, Henkin R, Karesh SM, Galie E, Berman DS. Comparison of myocardial imaging with iodine-123-iodophenyl-9-methyl pentadecanoic acid and thallium-201-chloride for assessment of patients with exercise-induced myocardial ischemia.J Nucl Med 32: 447–452, 1991.
2. Tamaki N, Kawamoto M, Yonekura Y, Fujibayashi Y, Takahashi N, Konishi J, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog.J Nucl Med 33: 659–667, 1992.
3. Takeishi Y, Atsumi H, Fujiwara S, Tomoike H. Delayed metabolic recovery of hibernating myocardium after percutaneous transluminal coronary angioplasty: Assessment with iodine-123-β-methyl-p-iodophenyl-pentadecanoic acid imaging.J Cardiol 28: 17–25, 1996.
4. Saitoh M, Hasegawa K, Hasegawa K, Kondoh T, Yanagaw T. Detection of coronary artery disease using 12-lead electrocardiogram and simultaneous dual myocardial imaging with iodine-123-β-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with unstable angina.Intern Med 34: 1064–1070, 1995.
5. Takeishi Y, Sukekawa H, Saito H, Nishimura S, Shibu T, Sasaki Y, et al. Impaired myocardial fatty acid metabolism detected by123I-BMIPP in patients with unstable angina pectoris: comparison with perfusion imaging by99mTc-sestamibi.Ann Nucl Med 9: 125–130, 1995.